GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
130 hedge funds and large institutions have $3.89B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
68% less call options, than puts
Call options by funds: $21.7M | Put options by funds: $68.8M
Holders
130
Holding in Top 10
3
Calls
$21.7M
Puts
$68.8M
Top Buyers
| 1 | +$97.5M | |
| 2 | +$93.6M | |
| 3 | +$53.4M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$44.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$44.5M |
Top Sellers
| 1 | -$58.7M | |
| 2 | -$27.4M | |
| 3 | -$10.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$9.91M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.58M |
